等待开盘 04-03 09:30:00 美东时间
+0.110
+1.89%
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Designer Brands业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **营收表现:** - 第四季度净销售额7.136亿美元,同比持平 - 全年净销售额29亿美元,同比下降3.9% - 第四季度可比销售额下降1.9%,全年可比销售额下降4.3% **盈利能力:** - 第四季度综合毛利率42.4%,同比提升280个基点 - 全年综合毛利率43.6%,同比提升90个基点 - 全年调整后营业利润6,520万美元,超出指导区间上限 - 第四季度调整后营业亏损1,100万美元,较去年同期2,350万美元亏损有所改善 **净利润:**
03-27 12:13
Designer Brands beats expectations on EPS and projects FY2026 EPS above street view, driving stock higher.
03-27 01:54
Gainers EpicQuest Education Group (NASDAQ:EEIQ) shares rose 75.8% to $4.8 duri...
03-26 20:05
Companies Reporting Before The Bell • ProShares UltraShort Russell2000 (NYSE:TW...
03-26 19:11
Designer Brands (NYSE:DBI) is looking for FY2026 GAAP EPS of $0.28-$0.38 vs $0.16 analyst estimate..
03-26 19:01
Designer Brands (NYSE:DBI) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(0.49) by 37.37 percent. This is a 29.55 percent increase over losses of $(0.44) per share from the
03-26 18:59
Designer Brands (DBI) will release earnings on March 26, with analysts expecting a quarterly loss of 49 cents per share. The stock gained 3% on Wednesday.
03-26 16:09
U.S. stock futures down, focus on earnings from Commercial Metals, Worthington Steel, Designer Brands, MillerKnoll, and Shoe Carnival.
03-26 15:30
今日重点评级关注:LUCID CAPITAL MARKETS:上调INmune Bio评级至"买入" 目标价从2美元升至9美元;Clear Street:维持MoonLake Immunotherapeutics Class A"买入"评级,目标价从45美元升至70美元
03-12 12:34
UBS analyst Jay Sole maintains Designer Brands (NYSE:DBI) with a Neutral and lowers the price target from $7.5 to $6.5.
03-12 04:10